Analysis of immunostimulatory activity of Porphyromonas gingivalis fimbriae conferred by Toll-like receptor 2

2010 ◽  
Vol 398 (1) ◽  
pp. 86-91 ◽  
Author(s):  
Yukari Aoki ◽  
Koichi Tabeta ◽  
Yukitaka Murakami ◽  
Fuminobu Yoshimura ◽  
Kazuhisa Yamazaki
Bone ◽  
2015 ◽  
Vol 81 ◽  
pp. 654-661 ◽  
Author(s):  
Yu-Hsiung Wang ◽  
Reza Nemati ◽  
Emily Anstadt ◽  
Yaling Liu ◽  
Young Son ◽  
...  

2017 ◽  
Vol 1861 (11) ◽  
pp. 2680-2689 ◽  
Author(s):  
M.S. Murgueitio ◽  
S. Ebner ◽  
P. Hörtnagl ◽  
C. Rakers ◽  
R. Bruckner ◽  
...  

2013 ◽  
Vol 81 (4) ◽  
pp. 1277-1286 ◽  
Author(s):  
Sumita Jain ◽  
Stephen R. Coats ◽  
Ana M. Chang ◽  
Richard P. Darveau

ABSTRACTInfection by the chronic periodontitis-associated pathogenPorphyromonas gingivalisactivates a Toll-like receptor 2 (TLR2) response that triggers inflammation in the host but also promotes bacterial persistence. Our aim was to define ligands on the surfaces of intactP. gingivaliscells that determine its ability to activate TLR2. Molecules previously reported as TLR2 agonists include lipopolysaccharide (LPS), fimbriae, the lipoprotein PG1828, and phosphoceramides. We demonstrate that these molecules do not comprise the major factors responsible for stimulating TLR2 by whole bacterial cells. First,P. gingivalismutants devoid of the reported protein agonists, PG1828 and fimbriae, activate TLR2 as strongly as the wild type. Second, two-phase extraction of whole bacteria resulted in a preponderance of TLR2 agonist activity partitioning to the hydrophilic phase, demonstrating that phosphoceramides are not a major TLR2 ligand. Third, analysis of LPS revealed that TLR2 activation is independent of lipid A structural variants. Instead, activation of TLR2 and TLR2/TLR1 by LPS is in large part due to copurifying molecules that are sensitive to the action of the enzyme lipoprotein lipase. Strikingly, intactP. gingivalisbacterial cells treated with lipoprotein lipase were attenuated in their ability to activate TLR2. We propose that a novel class of molecules comprised by lipoproteins constitutes the major determinants that confer toP. gingivalisthe ability to stimulate TLR2 signaling.


2009 ◽  
Vol 77 (10) ◽  
pp. 4414-4420 ◽  
Author(s):  
Koki Haruyama ◽  
Atsutoshi Yoshimura ◽  
Mariko Naito ◽  
Mami Kishimoto ◽  
Mikio Shoji ◽  
...  

ABSTRACT Porphyromonas gingivalis is a major periodontal pathogen that has the pathogenic proteinases Arg-specific gingipain and Lys-specific gingipain. We previously found that a cell surface component on P. gingivalis is able to induce Toll-like receptor 2 (TLR2)- and TLR4-independent signaling in 7.19 cells and that this component can be degraded by gingipains. In this study, we purified this component from the P. gingivalis gingipain-null mutant KDP136 and obtained two candidate proteins. Matrix-assisted laser desorption ionization-time-of-flight mass spectrometry analysis showed that the proteins, with molecular masses of 123 and 43 kDa, were encoded by PGN_0748 and PGN_0728 (pgm6), respectively, in the P. gingivalis ATCC 33277 genome sequence. The PGN_0748-encoded protein, which we refer to as gingipain-sensitive ligand A (GslA), reacted with antiserum that could effectively inhibit the activity of KDP136 to induce NF-κB activation in 7.19 cells, but Pgm6 did not. To further determine what protein is responsible for the NF-κB activation, we constructed gslA, pgm6, and pgm6 pgm7 deletion mutants from KDP136. When 7.19 cells were exposed to those mutants, the gslA deletion mutant did not induce NF-κB activation, whereas the pgm6 and pgm6 pgm7 deletion mutants did. Furthermore, NF-κB activation in 7.19 cells induced by KDP136 was partially inhibited by antiserum against a recombinant protein expressed from the 5′-terminal third of gslA. These results indicate that GslA is one of the factors that induce NF-κB activation in 7.19 cells. Interestingly, the gslA gene was present in four of seven P. gingivalis strains tested. This restricted distribution might be associated with the virulence potential of each strain.


2017 ◽  
Vol 247 ◽  
pp. 182-193 ◽  
Author(s):  
Malvina Pizzuto ◽  
Monique Gangloff ◽  
Daniel Scherman ◽  
Nicholas J. Gay ◽  
Virginie Escriou ◽  
...  

2010 ◽  
Vol 18 (2) ◽  
pp. 235-242 ◽  
Author(s):  
Yumiko Tsukamoto ◽  
Masumi Endoh ◽  
Tetsu Mukai ◽  
Yumi Maeda ◽  
Toshiki Tamura ◽  
...  

ABSTRACTPreviously, we observed that both major membrane protein II ofMycobacterium leprae(MMP-ML) and its fusion withM. bovisBCG (BCG)-derived heat shock protein 70 (HSP70) (Fusion-ML) are immunogenic and that recombinant BCG secreting either of these proteins effectively inhibits the multiplication ofM. lepraein mice. Here, we purifiedM. tuberculosis-derived major membrane protein II (MMP-MTB) and its fusion with HSP70 (Fusion-MTB) in a lipopolysaccharide-free condition and evaluated their immunostimulatory abilities. Both MMP-MTB and Fusion-MTB activated monocyte-derived dendritic cells (DC) in terms of phenotype and interleukin-12 (IL-12) production, but Fusion-MTB more efficiently activated them than MMP-MTB did. The IL-12 production was a consequence of the ligation of those recombinant proteins with Toll-like receptor 2. TheM. tuberculosis-derived andM. leprae-derived recombinant proteins activated naïve T cells of both CD4 and CD8 subsets, butM. tuberculosis-derived proteins were superior toM. leprae-derived proteins and fusion proteins were superior to MMP, regardless of the origin of the protein. Memory-type CD4+T cells obtained from BCG-vaccinated healthy individuals seem to be primed with MMP-MTB by the vaccination, and bothM. tuberculosis-derived recombinant proteins produced perforin-producing CD8+T cells from memory-type CD8+T cells. Further, infection of DC and macrophages withM. tuberculosisH37Ra and H37Rv induced the expression of MMP on their surface. These results indicate thatM. tuberculosis-derived MMP, as a sole protein or as part of a fusion protein, may be useful for developing new vaccinating agents against tuberculosis.


Sign in / Sign up

Export Citation Format

Share Document